In late November, the Biden administration proposed extending coverage of breakthrough anti-obesity drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound to Medicaid and Medicare patients. If ...

Digging Into the Bargain Bin Investing in beaten-down stocks can be a savvy strategy for long-term wealth creation, as it ...